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H]thymidine incorporation vs. Ad-LacZ-infected controls. We suggest that negative modulation of R-Smad phosphorylation by ectopic I-Smad7 may contribute to the downregulation of collagen in cardiac myofibroblasts and may suppress the proliferation of these cells. Thus treatments targeting the collagen deposition by overexpression of I-Smad7 may provide a new therapeutic strategy for cardiac fibrosis. myofibroblast; cardiac remodeling; matrix metalloproteinase; p27; fibroblast proliferation; cardiac fibrosis AFTER LEFT VENTRICULAR (LV) myocardial infarction (MI), the infarcted myocardium undergoes wound healing and accelerated matrix deposition (59) , a critical component of cardiac wound healing. In time, interstitial fibrosis of the noninfarcted or remnant heart also occurs and is associated with increased myocardial stiffness. Excessive wound repair is characterized by marked interstitial cardiac fibrosis, and myofibroblast proliferation contributes to the development of cardiac hypertrophy and heart failure (23) .
Transforming growth factor-␤ (TGF-␤) is a major regulator of cardiac fibrosis during the development of cardiac hypertrophy (13, 29, 44) . TGF-␤ enhances matrix deposition by increasing the synthesis of matrix components such as collagen and fibronectin (30) . Moreover, TGF-␤ promotes the expression of inhibitors of extracellular matrix proteases, such as plasminogen activator inhibitor and tissue inhibitors of matrix metalloproteinases (TIMPs) while simultaneously downregulating interstitial collagenases that function to degrade matrix components (39, 45) . We have previously demonstrated the activation of matrix metalloproteinase-2 (MMP-2) in murine heart after large MI (49) .
TGF-␤ signaling is initiated through binding to a transmembrane heteromeric type I (T␤RI) and type II (T␤RII) receptor complex that normally displays serine/threonine kinase activity (62) . After the activation of the receptor, the signal is transferred to the nucleus through Smad proteins (16, 26) . The Smad family consists of receptor-regulated Smads (R-Smad, Smad2, and Smad3), common mediator Smad (Co-Smad4), and inhibitory Smads (I-Smad6 and I-Smad7; see Ref. 31 ). Upon TGF-␤ binding, R-Smad is phosphorylated by T␤RI and complexes with Co-Smad 4, which translocates to the nucleus to interacting with DNA-binding partners and transcriptional coactivators and corepressors (11, 61) . Cellular responsiveness to TGF-␤ signaling is controlled via mechanisms in the extracellular space, at the membrane, and in the cytoplasm and nucleus.
A well-described function of inhibitory I-Smad7 lies in the autoinhibition of R-Smad signaling; to do this, it associates with activated T␤RI to inhibit phosphorylation and activation of R-Smads (35) . Although TGF-␤ is a major regulator of I-Smad7 activation, other cytokines, i.e., interferon-␥ and tumor necrosis factor-␣, are known to contribute to transcriptional regulation of this protein (34, 54) . I-Smad7 antagonizes growth inhibition and the induction of apoptosis and embryonic lung morphogenesis induced by TGF-␤ 1 (20, 21, 43, 64) . Because long-term (7 days at 10 ng/ml) TGF-␤ 1 treatment inhibits [ 3 H]thymidine incorporation and proliferation of myofibroblasts in culture (37), we hypothesized that this is the result of reciprocal activation of I-Smad7. Thus we sought to characterize the effect of ectopic I-Smad7 in our in vitro cardiac myofibroblast system on p27 as a key point of inhibition of cell cycle progression. We also examined the proliferative effect of the ectopic overexpression of I-Smad7 in cardiac myofibroblast using the [ 3 H]thymidine incorporation technique.
Our data reflect a relatively early decrease in I-Smad7 expression in infarct scar and remnant LV tissues from post-MI hearts, indicating a potential role of I-Smad7 in the develop-ment of cardiac fibrosis in post-MI heart (58) wherein cardiac myofibroblasts contribute to cardiac repair. Furthermore, bleomycin-induced lung fibrosis, which is mediated by consistent activation of TGF-␤ 1 , is prevented by the administration of exogenous (adenoviral delivery) I-Smad7 (36) . Nevertheless, surprising little is known of control of matrix turnover by I-Smad7 in cardiac myofibroblasts. Thus we sought to define I-Smad7 modulation of collagen in cultured cardiac myofibroblasts by addressing collagen synthesis and MMP expression in cells overexpressing I-Smad7.
MATERIALS AND METHODS
Primary adult cardiac myofibroblast culture. Adult cardiac myofibroblast cultures were established from ventricular tissue of male Sprague-Dawley rats according to the methods of Brilla et al. (5) with minor modifications (22) . Adult rats (175-200 g body mass) were killed, and hearts were subjected to Langendorff perfusion with a flow of 5 ml/min at 37°C with recirculating Joklik's medium containing 0.1% collagenase (chaotropic agent) and 2% BSA for 25-35 min. Liberated cells were collected by centrifugation at 2,000 rpm for 10 min. Cells were resuspended in DMEM-F-12 and plated on a 100-mm noncoated culture flask at 37°C with 5% CO 2 for 2 h. Cardiac fibroblasts attached to the bottom of the culture flask during a 2-h incubation, whereas nonadherent myocytes were removed by changing the culture medium. The cells were maintained in DMEM-F-12 supplemented with 10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, and 10 Ϫ4 M ascorbate. The cells used for the study were from the second passage (P2); TGF-␤1 treatment was initiated after 48 h incubation of cells in DMEM-F-12 in the absence of serum. I-Smad7 adenovirus was added to the cultured cells 24 h before TGF-␤ 1 stimulation. The purity of fibroblasts used in these experiments was found to be Ն95%, using routine phenotyping methods described previously (22) . Briefly, endothelial cells were labeled with the use of a monoclonal antibody against factor VIII, and we found that less than ϳ1% of cultured cells were positive for this protein.
Less than 1% of cells were positive for desmin, which is specific for smooth muscle cells, and Ͼ95% of cells stained positively for procollagen type 1, which is a major protein product of fibroblasts. However, passaged fibroblasts (P1 and P2 cells) that have been cultured in DMEM-F-12 containing 10% FBS for up to at least 5 days demonstrated significant markers for myofibroblast phenotype, i.e., ␣-smooth muscle actin and SMemb.
Recombinant adenovirus. Replication-deficient human adenovirus vector expression mouse I-Smad7 under the control of CMV promoter (AdvCMVSmad7) is kindly provided by Dr. Anita Roberts (NIH, Bethesda, MD). Expression of the ecotopic I-Smad7 in cardiac myofibroblasts was confirmed by Western blot with anti-flag antibody (Sigma, Oakville, Ontario, Canada). AdvCMVLacZ encoding ␤-galactosidase was chosen as a control in the experiments. In situ X-Gal staining was used to confirm the infection efficiency of I-Smad7 adenovirus at 100 multiplicity of infection (MOI) is Ͼ95% in cardiac myofibroblasts.
Protein extraction and assay. Cardiac myofibroblasts infected with I-Smad7 adenovirus (100 MOI) in the absence or presence of TGF-␤ 1 (10 ng/ml) for indicated time were washed with cold PBS, and total proteins were isolated using RIPA buffer containing proteinase inhibitors and phosphatase inhibitors (10 mM NaF, 1 mM sodium orthovanadate, and 20 mM ␤-glycorophosphate). The cell lysate was incubated on ice for 1 h and then sonicated for 5 s (repeated 3 times). After centrifugation at 16,000 g for 15 min at 4°C, the supernatant was used for the total protein assay. Total protein concentration of all samples was measured using the bicinchoninic acid method as described previously (46) .
Western blot analysis of target proteins. Prestained low-molecularweight marker (Bio-Rad, Hercules, CA) and 20 g of protein from samples were separated on 10 or 12% SDS gels by SDS-PAGE. Separated protein was transferred on a 0.45 M polyvinylidene difluoride (PVDF) membrane that was blocked at room temperature for 1 h or overnight at 4°C in Tris-buffered saline with 0.2% Tween 20 (TBS-T) containing 5% skim milk and probed with primary antibodies for 1 h at room temperature. The primary antibody against phosphorylated R-Smad2 was diluted 1:250 in 0.2% TBS-T with 5% skim milk, whereas the total R-Smad2 primary antibody was diluted 1:200 in 0.2% TBS-T with 5% skim milk. The primary antibody for actin was diluted 1:500 in 0.2% TBS-T with 5% skim milk. Phosphorylated (P) extracellular signal-regulated kinase (ERK) and P-c-Jun NH 2-terminal kinase (JNK) antibodies were diluted 1:250 in 0.2% TBS-T with 5% skim milk, and p27 primary antibodies were diluted 1:1,000; phospho-Rb primary antibodies were diluted 1:500. Secondary antibodies included horseradish peroxidase (HRP)-labeled antirabbit for phosphorylated R-Smad2 and anti-mouse for total R-Smad2, actin, P-ERK, and P-JNK. All secondary antibodies were diluted 1:10,000 with 0.2% TBS-T with 1% skim milk and incubated for 1 h at room temperature. Protein bands on Western blots were visualized by ECL Plus (Amersham, Arlington Heights, IL) according to the manufacturer's instructions and were developed on film or using a Molecular Dynamics chemiluminescence detector (Storm 860; Amersham-Pharmacia Baie d'Urfé, PC, Canada). Relatively even protein loading was confirmed by immunoblotting against actin.
Immunodetection of MMP-2, MT1-MMP, and TIMP2. Cardiac myofibroblasts were cultured until confluent, and the medium was changed to DMEM-F-12 in the absence of serum. After a 24-h incubation, I-Smad7 (100 MOI), LacZ (100 MOI) adenovirus, and TGF-␤ 1 (10 ng/ml) were added to the medium. The conditioned media was collected at 24 h TGF-␤1 stimulation and/or I-Smad7 adenovirus administration. The expression of MMP-2, MT1-MMP, and TIMP in the I-Smad7-infected cells was examined by Western blot analysis. Sample proteins (i.e., conditioned media) were prepared under reducing condition, and separated on 10% SDS-PAGE (for MMP-2 and MT1-MMP) or 12% SDS-PAGE (for TIMP-2). Separated proteins (40 g) were electrically transferred on PVDF membranes (Bio-Rad). After the nonspecific background was blocked with 5% milk in TBS-T, PVDF membranes were incubated with the antibodies for anti-rabbit polyclonal MMP-2 (AB809; 1:1,000), MT1-MMP (AB8221; 1:1,000), and TIMP-2 (AB8107; 1:1,000) for 1 h at room temperature. After the membrane was washed with Tween 20 buffer, the membranes were incubated with goat anti-rabbit HRP (1:10,000) for 1 h at room temperature. The immunoreactive bands were then visualized by ECL Plus detection (Amersham) according to the manufacturer's instructions and were developed on film. The even loading was confirmed by incubating membranes in Ponceau S solution (0.1% Ponceau S in 5% acetic acid; Sigma).
Hydroxyproline assay. To test the total collagen production, primary cardiac myofibroblasts were seeded in equal numbers in 100-mm cell culture dishes and grown until confluent in DMEM-F-12 with 10% FBS and 50 g/ml ascorbic acid. Cells were starved for 48 h before the addition of TGF-␤1 and I-Smad7 adenovirus. After 72 h treatment, cells were scraped on the cell culture medium of 100-mm dishes. Both the cell lysate and culture medium were removed and placed in test tubes, and net collagen production was determined with a hydroxyproline-based assay as described previously (56) . The result was expressed as degree of increase against values from control cardiac myofibroblasts.
[ 3 H]thymidine incorporation. Proliferation assays were done on cells cultured on 24-well plates at a density of 0.2 ϫ 10 6 cells/well (counted with a hemocytometer) in DMEM-F-12 with 10% FBS. After the cells reached ϳ60% confluency, medium was replaced with DMEM-F-12 ϩ 0% FBS, 10% FBS, or 2% FBS. Cells were infected with 100 MOI I-Smad7 adenovirus vector for 24 h. Other groups of cells were starved for 24 h and then 10 ng/ml of TGF-␤1 were added to the media for 24 h. Cells were then pulsed for 4 h at room temperature with 2. Reagents. Primary antibodies against P-ERK, P-JNK, and actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The primary antibody specific to phosphorylated Ser 465/467 R-Smad2 was obtained from Calbiochem (San Diego, CA). Total R-Smad2 primary antibody was purchased from Cell Signaling (Beverly, MA). The primary antibodies against MMP-2, MT1-MMP, and TIMP-2 were obtained from Chemicon (Temecula, CA). HRP-labeled anti-mouse and HRP-labeled anti-rabbit secondary antibodies were purchased from Bio-Rad. TGF-␤ 1 peptide was purchased from R&D Systems (Minneapolis, MN).
Statistics. All values are expressed as means Ϯ SE. One-way ANOVA followed by Student-Newman-Keuls post hoc analysis was used to compare the differences among multiple groups (SigmaStat, Point Richmond, CA). Significant differences among groups were defined by P Յ 0.05.
RESULTS
Net collagen content in cardiac myofibroblasts overexpressing ectopic I-Smad7. To determine if the protein level of the main component of extracellluar matrix, i.e., collagen, is altered by overexpression of ectopic I-Smad7, total collagen content was determined in adult cardiac myofibroblasts using hydroxyproline assay. As shown in Fig. 1 , data were expressed as degree of increase units against the mean control value for each experiment. Exposure of cardiac myofibroblasts to TGF-␤ 1 (5 ng/ml) for 3 days was associated with marked increase of total collagen production compared with the control group. However, infection of the adult cardiac myofibroblasts with I-Smad7 adenovirus resulted in significant attenuation of net collagen production in the absence and presence of TGF-␤ 1 treatment compared with LacZ-infected myofibroblasts.
Prolonged activation of P-Smad2 by TGF-␤ 1 in adult primary cardiac myofibroblasts. Although it is known that TGF-␤ 1 functions to activate R-Smads in different cell types, we examined the specific activation pattern of phosphorylated Smad2 in primary cardiac myofibroblasts. The cells were cultured with TGF-␤ 1 at indicated time points (5 min, 30 min, 1 h, 6 h, and 12 h) following starving in DMEM-F-12 containing 0% serum for 48 h. Phosphorylated Smad2 (P-Smad2) and total Smad2 expression were measured by Western blot analysis ( Fig. 2A) . We found that the expression level of P-Smad2 in quiescent cardiac fibroblasts is fairly low, and it was observed to increase at 5 min TGF-␤ 1 stimulation. It peaked at 30 min TGF-␤ 1 treatment and remained activated until 12 h treatment of TGF-␤ 1 . Dose-dependent Smad2 activation by TGF-␤ 1 was also investigated in the current study (Fig. 2B) ; however, we found no significant alteration of P-Smad2 expression in cardiac myofibroblasts stimulated with different doses of TGF-␤ 1 ranging from 0.5 to 10 ng/ml.
Blockade of expression of P-Smad2 by ectopic I-Smad7 in cultured cardiac myofibroblasts. As an intracellular negative regulator of TGF-␤ signal, I-Smad7 was reported to inhibit the phosphorylation of Smad2 in a variety of cell types. To determine the effect of ectopic I-Smad7 on the expression and activation of Smad2 in cultured cardiac myofibroblasts, protein was extracted from myofibroblasts following overexpression of I-Smad7 via an adenovirus system. X-Gal staining showed Ͼ95% cells were positive in the infection of 100 MOI (data not shown). Furthermore, high-level expression of the protein in cardiac myofibroblasts was also confirmed by Western blot analysis using anti-flag antibody (data not shown). After adding I-Smad7 adenovirus to cells 24 h before TGF-␤ 1 stimulation, we observed that ectopic overexpression of I-Smad7 was associated with blockade of the synthesis of TGF-␤-induced P-Smad2 compared with LacZ controls, and this inhibitory effect is TGF-␤ 1 stimulation time point dependent. As shown in Fig. 3 , P-Smad2 was significantly elevated following TGF-␤ 1 stimulation at 1, 2, and 6 h. Although ectopic I-Smad7 decreased the expression of Smad2 in the absence of TGF-␤ 1 treatment, it failed to block the activation of P-Smad2 induced by TGF-␤ 1 at the earlier time points, i.e., 1 and 2 h stimulation (Fig. 3, A and B) . However, at 6 h TGF-␤ 1 treatment, this TGF-␤ 1 -mediated R-Smad2 activation process was markedly attenuated by forced expression of I-Smad7 in cardiac myofibroblasts. Moreover, the expression level of total Smad2 was not altered across untreated or I-Smad7-and LacZ-infected cultures. We found the attenuation of Smad2 activation by ectopic I-Smad7 was achieved in a dose-dependent manner (Fig. 4) .
Effect of overdriven I-Smad7 on mitogen-activated protein kinases activation in cardiac myofibroblasts.
It is well known that TGF-␤ can activate mitogen-activated protein kinases (MAPK) signaling pathway, including JNK and ERK (2, 18) . As important downstream effectors of the TGF-␤ signal pathway, they have also been implicated in TGF-␤-regulated collagen deposition (15, 60) . We suggest that the inhibitory role of I-Smad7 on collagen accumulation in cardiac myofibroblast may be partially mediated by MAPKs. As indicated in Fig. 5 , we found markedly decreased expression of P-ERK in I-Smad7 adenovirus-infected cells compared with control LacZ-expressing cells. However, the activation of ERK induced by 1 h TGF-␤ 1 stimulation was not completely blocked by ectopic I-Smad7 protein. Additionally, forced expression of I-Smad7 exerted no effect on activation of JNK in cardiac myofibroblasts in the presence or absence of 1 h TGF-␤ 1 treatment.
Regulation of synthesis of MMP components and TIMPs by I-Smad7 in cultured cardiac myofibroblasts. TGF-␤ has been
implicated in the modulation of MMPs, a family of proteolytic enzymes that function to degrade all the matrix components of the heart and thus serve in cardiac matrix turnover. To assess whether ectopic I-Smad7 exerts effect on the cardiac expression of MMPs, we obtained conditioned cell medium from cardiac fibroblasts infected with Ad Smad7 at 100 MOI. Western blot was then carried out to examine the expression level of MMP-2 in the culture medium. The data revealed that overdriven I-Smad7 significantly increased expression of immunoreactive 65-kDa MMP-2 protein (the active form of this MMP) in culture medium of myofibroblasts compared with LacZ-infected cells (Fig. 6) . Expression of the 72-kDa MMP-2 variant (i.e., inactive form of this MMP) was not altered by exogenous I-Smad7 transfection/overexpression. Given that the activation process of MMP-2 requires the formation of a ternary complex composed of pro-MMP-2, MT1-MMP, and Fig. 3 . Representative Western blot analysis of P-Smad 2 expression in primary cardiac myofibroblasts infected with adenoviral I-Smad7 [S7, 100 multiplicity of infection (MOI)] in the presence and absence of TGF-␤1 treatment (T; 10 ng/ml). A: expression of P-Smad 2 in adenovirus-infected myofibroblasts treated with TGF-␤1 at 1 h. B: expression of P-Smad 2 in adenovirus-infected myofibroblasts treated with TGF-␤1 at 2 h. C: expression of P-Smad 2 in adenovirus-infected myofibroblasts treated with TGF-␤1 at 6 h. Constitutive expression P-Smad 2 is dramatically decreased in ectopic I-Smad7-infected cells compared with cells infected with control LacZ adenovirus. However, the TGF-␤1-induced expression of P-Smad 2 was attenuated in myofibroblasts stimulated with TGF-␤1 at 6 h. TIMP-2, immunodetection of these proteins was performed on the same samples to further investigate the possibility that alterations in these protein expressions may lead to the accelerated processing of pro-MMP-2 into MMP-2. We observed a significant increase of pro-MT1-MMP in the culture medium of cardiac myofibroblasts infected with I-Smad7 adenovirus compared with LacZ-infected controls (Fig. 6) . However, no difference regarding synthesis of TIMP-2 was defined in cells overexpressing I-Smad7.
Influence of ectopic I-Smad7 on expression of p27 and phospho-Rb. Overexpressed I-Smad7 was associated with a significant increase of the p27-to-␤-tubulin ratio in myofibroblasts in 2% FBS-DMEM vs. values derived from Lac-Zinfected controls, noninfected 10% serum-treated cells, and 2% noninfected serum-treated cells (Fig. 7) . Conversely, ectopic I-Smad7 was associated with a significant decrease of the ratio phospho-Rb/␤-tubulin protein band intensity in myofibroblasts (in 2% FBS-DMEM media) vs. values of Lac-Z-infected cells in 2% serum as well as noninfected 2 and 10% serum cultured cells (Fig. 7) . Thus I-Smad7 overexpression was associated with a decreased level of phospho-Rb protein under these current culture conditions. Ectopic I-Smad7 is associated with decreased cardiac myofibroblast proliferation. The effect of ectopic I-Smad7 on primary myofibroblast [ 3 H]thymidine incorporation in lowserum conditions (FBS-DMEM-F-12) was tested. Thymidine incorporation was significantly inhibited by I-Smad7-vs. Lac-Z-infected controls in 2% FBS-DMEM-F-12 as well as noninfected 2% serum-treated and 10% serum-treated cells (Fig. 8) .
DISCUSSION
Excessive collagen deposition or pathological fibrosis is an important contributor to LV dysfunction. The abnormal deposition of collagen in various etiologies of heart disease has a dual effect. Although its tensile strength protects the injured heart from dilatation and rupture of the infarcted region, excessive matrix deposition leads to cardiac fibrosis, which impairs the already attenuated cardiac function. Therefore, antifibrotic agents that target steps in collagen synthesis and degradation pathways represent promising strategies for these diseases. TGF-␤ is an important player in the fibrosis of a variety of tissues, including cardiac tissues. Previous evidence of blockade of TGF-␤ signal with antisense, neutralizing antibody or decorin has highlighted the therapeutic potential by targeting this molecule in pathological fibrosis (1, 19, 27) . Following the binding of the TGF-␤ ligand to T␤RII, T␤RI is activated, which leads to the phosphorylation of R-Smads, including Smad2 and Smad3, and subsequently initiates the transduction of TGF-␤ signal. On the other hand, activated T␤RI receptor also functions to induce the expression of I-Smad7, which antagonizes TGF-␤ signaling either by competing for binding of R-Smads to T␤RI, thereby blocking R-Smads from interacting with the receptor (14, 52) , or by increasing ubiquitin-mediated degradation of TGF-␤ receptor (25) . Although touted as a putative means to block canonical TGF-␤ signaling (58) , information of the effects of I-Smad7 expression is incomplete.
Some lines of evidence have pointed to the negative regulatory role of I-Smad7 in the activation of R-Smads in a variety of tissues. For example, overexpression of I-Smad7 was shown to attenuate Smad2/3-mediated inhibition of embryonic morphogenesis (63, 64) . In bleomycin-induced lung fibrosis, ectopic I-Smad7 was also associated with inhibition of Smad2 phosphorylation, decreased type I procollagen mRNA, and net collagen production (36) . Moreover, blockade of activation of Smad2 and downregulation of collagen type I, III, and IV was observed in renal tubular epithelial cells (50) and smooth muscle cells (24) overexpressing I-Smad7. In hepatic stellate cells, ectopic expression of I-Smad7 also leads to abrogation of Smad2 activation (8) . Data from our laboratory have shown that I-Smad7 expression was decreased in both scar tissue and remnant tissue in post-MI rat hearts, accompanied by decreased cytosolic expression of phosphorylated Smad2 (58) . Although this in vivo study implies that abnormal expression of I-Smad7 may play a role in cardiac fibrosis, the underlying mechanisms remain unclear.
In this study, we found that the marked prolonged activation of Smad2 by TGF-␤ 1 was effectively blocked by ectopic expression of I-Smad7 in both a dose-dependent and timedependent manner, suggesting I-Smad7 prevented TGF-␤ 1 -mediated phosphorylation of Smad2 in cardiac myofibroblasts. However, this inhibitory effect was specifically on the activation process, given the fact that adenovirus-mediated I-Smad7 overexpression did not alter total Smad2 expression. Moreover, consistent with our published in situ immunostaining analysis showing decreased expression of both collagen type I and type III in primary cardiac myofibroblasts overexpressing ectopic I-Smad7 (58), we now demonstrate that overdriven I-Smad7 significantly attenuated total collagen synthesis induced by TGF-␤ 1 . Together the data indicate that blockade of Smad2 activation by overexpression of exogenous I-Smad7 may result in inhibition of TGF-␤ 1 -induced collagen deposition. This association between Smad2 activation and synthesis of collagen also supports that phosphorylated Smad2 may play a major role in the transcriptional regulation of collagen promoter, a process requiring nuclear translocation of P-Smad2. To further investigate whether nuclear translocation of P-Smad2 was also involved in the regulation of collagen production by I-Smad7, we performed immunofluorescence analysis of Smad2 localization following I-Smad7 adenovirus administration. However, no significant inhibition of the nuclear translocation of P-Smad2 by overexpression of I-Smad7 was found in adult cardiac myofibroblasts (data not shown). Therefore, attenuation of collagen synthesis in cardiac myofibroblasts caused by overdriven I-Smad7 may be mediated by decreased expression of P-Smad2 and not by blockade of nuclear translocation of P-Smad2.
In addition to traditional Smad-mediated transcriptional activation, TGF-␤-induced activation of the MAPK pathways has also been shown to play a role in TGF-␤-responsive biological consequences, including collagen deposition (40, 55) . Although cross talk between Smad proteins and MAPKs has been implicated in the modulation of Smad phosphorylation and translocation, MAPK pathway activation may precede and be independent from Smad protein activation (10) . To address the possible effect of I-Smad7 on the activation of JNK and ERK kinases, we performed Western blot analysis of these MAPKs in cardiac myofibroblasts overexpressing I-Smad7 protein. Although we observed attenuation of P-ERK expression by overdriven I-Smad7, the 1-h-TGF-␤ 1 -induced activation of ERK was not ablated by I-Smad7 protein, suggesting that blockade of ERK activation via I-Smad7 may be achieved in a TGF-␤-independent manner. In addition to the induction of JNK by TGF-␤ 1 , ectopic expression of I-Smad7 has been indicated to synergistically cause a significant stimulation of JNK activity in Mv1Lu cells (32) . However, in cardiac myofibroblasts overexpressing I-Smad7 proteins, we did not observe induction of JNK activity either by TGF-␤ 1 or overdriven I-Smad7 protein. Thus the data indicate that ERK may play a more important role than JNK in I-Smad7-mediated downregulation of collagen production in cardiac myofibroblasts.
MMPs play a crucial role in the remodeling process of myocardium following MI (47, 51) . MMP-2, also known as gelatinase A, is important in maintenance of cardiac matrix, since this metalloproteinase may process denatured collagen and gelatins. The mechanism underlying activation of pro-MMP-2 is known to implicate other MMPs such as MMP-1 (7), autoactivation (3), and the urokinase plasminogen system (33) . MMP-2 activation is also mediated by MT-MMP1 (41), which requires the assistance of TIMP-2, which functions as a linker between MT1-MMP and pro-MMP-2 to form a ternary complex at the cell surface (48) . Few studies have revealed the importance of I-Smad7 in the activation process of MMPs, and we found that ectopic I-Smad7 protein was associated with accelerated activation of pro-MMP-2 in cardiac myofibroblasts. The concomitant increase of MT1-MMP expression is notable, since it may contribute to the proteolytic cleavage of pro-MMP-2 to MMP-2. Although TIMP-2 is also necessary for the proteolysis of MMP-2 (4), the role of TIMP-2 in cardiac myofibroblasts may be secondary, since its expression is unchanged in the presence of overdriven ectopic I-Smad7 when compared with controls. Nevertheless, because the binding of TIMP-2 to MMP-2 as well as MT1-MMP affects the enzymatic activity of MMP-2 (6), further study may be needed to clarify the precise role of TIMP-2 in the regulation of MMP-2 activation by I-Smad7.
MMP expression can be modified at the transcriptional level by a variety of physiological signals, including growth factors and cytokines. Despite the induction of MMP-2 by I-Smad7, exposure of the quiescent cardiac myofibroblasts to TGF-␤ 1 was not associated with any marked alteration of MMP-2 activity as observed in other cell types (9, 57). As mentioned above, I-Smad7 has been shown to be able to exert a TGF-␤-independent regulatory effect on gene transcription (38) , and thus whether activation of MMP-2 by I-Smad7 acts via the TGF-␤ signal remains unclear. Because we found that the treatment of myofibroblasts with TGF-␤ led to upregulation of MT1-MMP, the effect of overexpression of I-Smad7 parallels that of the ligand. This could be caused either by complete disruption of the TGF-␤-I-Smad7 regulatory loop, or more likely, by a TGF-␤-independent I-Smad7 signaling path. The latter possibility seems plausible in view of the recent suggestion that I-Smad7 is complex, and possibly pleuripotent (12) . We suggest that overdriven I-Smad7 may induce the disruption of MT1-MMP-dependent processing of pro-MMP2, partially contributing to downregulated collagen synthesis.
The application of agents that target myofibroblast cell cycle progression and thus proliferation represent promising strategies for managing global cardiac fibrosis. The cyclin-dependent kinase inhibitors are important in cell cycle progression in normal cells (42, 53) . In cultured myofibroblasts, we found that ectopic I-Smad7 is associated with a significant increase in p27 expression. Because p27 inhibits the formation of the cdk2/ cyclin E complex, it is a salient marker for cell cycle inhibition. We also found that the phospho-Rb expression was significantly decreased by I-Smad7 overexpression in myofibroblasts, thus potentially limiting cell cycle progression at the G 1 phase as previously suggested (17, 28) . In combination with data showing reduced proliferation in transfected cells, we suggest that altered p27 and phospho-Rb expression may be ratelimiting factors in regulating the cell cycle in myofibroblasts when influenced by ectopic I-Smad7.
In conclusion, we provide evidence that ectopic expression of I-Smad7 appears to inhibit TGF-␤-induced collagen production in primary cardiac myofibroblasts. This antifibrotic effect of I-Smad7 involved both TGF-␤-dependent activation of Smad2 and TGF-␤-independent activation of MMP-2. Finally, overdriven I-Smad7 is also associated with inhibition of proliferation of myofibroblasts. Modification of TGF-␤ signaling by ectopic I-Smad7 may allow for the development of therapeutic strategies to attenuate post-MI cardiac fibrosis.
